Jefferies Outlines CVS Health (CVS) COVID Vaccine Opportunity, Reiterates $90 PT
Tweet Send to a Friend
Jefferies analyst Brian Tanquilut reiterated a Buy rating and $90.00 price target on CVS Health (NYSE: CVS) noting that investor ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
